200 Technology Square
Cambridge , MA 02139
Cambridge , MA 02139
News
-
Moderna Inc. declined 20% to $33.72 after the biotech company lowered its 2025 revenue range to between $1.5 billion and $2.5 billion, a decrease of $1 billion from the previous estimate as the company continues its operating costs.
The revised outlook is lower than the previous outlook between $2.5 billion and $3.5 billion issued in September.
Jan 13, 2025
Executive/
Director
Links
Price
- Last Close
-
$ 42.19
$ +0.17 0.4 %
Jan 3, 2025
- 52-Week High/Low
- $154.86 - $69.51
- YTD
- 1.5%
- Trading Volume
- 228,758
- Market Cap Full
- $ 16.1B
- Shares Outstanding
-
381.3M
Oct 27, 2023
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | -49.8% | 86.7% | - | 33.3% | -5% | 25.4% | -32.2% | -14.5% | 7.4% | 1.5% |
| Q2 | 16.5% | 35.7% | -91.1% | -30% | 4% | 79.4% | -17.1% | -20.9% | 15.1% | - |
| Q3 | -16.1% | -29% | -91.1% | 5.7% | 8% | 63.8% | -17.2% | -15% | -34.3% | - |
| Q4 | 15.4% | -38.9% | -17.9% | 21.7% | 43.6% | -34% | 51.9% | -3.7% | -11.3% | - |
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 1.5% | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | 1.6% | -8.7% | 15.8% | -5.1% | 40.3% | -14.6% | -2.3% | -34.3% | - | - | - | -3.3% |
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -60% | -43% | 10% | 825% | 26% | 445% | 143% | -29% | -45% | -58% | 1% |
Earnings
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|
| Q1 | 0.05 | 0.01 | -1.16 | -0.4 | -0.35 | 2.84 | 8.58 | 0.19 |
| Q2 | 0.08 | - | -1.43 | -0.41 | -0.31 | 6.46 | 5.24 | -3.62 |
| Q3 | 0.05 | 0.10 | -1.32 | -0.37 | -0.59 | 7.7 | 2.53 | -9.53 |
| Q4 | - | - | - | -0.37 | -0.71 | 11.29 | 3.77 | - |
| A | 0.2 | 0.1 | -3.9 | -1.6 | -2 | 28.3 | 20.1 | -12.96 |
Annual Returns
52 Week
High/Low
Annual
Earnings
Chart
Trading Volume
Outstanding Shares
(In Millions) +
Jan 16, 2024
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Mar | 329 | 368.6 | 399.8 | 402.9 | 386.3 |
| Jun | 329 | 371.2 | 401.5 | 397.8 | 381.2 |
| Sep | 330.2 | 394.6 | 403.6 | 391.2 | 380.6 |
| Dec | 333.3 | 395.7 | 405.4 | 384.2 | 381.3 |
SEC Filings
Financial Ratios
| 2022 | 2021 | 2020 | 2019 | 2018 | |||
|---|---|---|---|---|---|---|---|
| Asset Management | |||||||
| Inventory / Stock Turnover | 5.7 | 1.8 | 0.2 | - | - | ||
| Fixed Asset Turnover | 1.7 | 2.3 | 0.9 | 0.2 | 0.3 | ||
| Total Asset Turnover | 0.7 | 0.8 | 0.1 | - | 0.1 | ||
| Leverage | |||||||
| Interest Coverage | 8.9 | 12.2 | 47.7 | 17.1 | 14.8 | ||
| Debt Ratio | - | - | - | - | - | ||
| Debt – Equity Ratio | - | - | - | - | - | ||
| Equity multiplier | 0.6 | 0.6 | 0.4 | 0.3 | 0.3 | ||